目的：探讨瑞格列奈治疗2型糖尿病患者的临床疗效以及使用安全性。
Objective: to study the nanotubes raigor column treatment of type 2 diabetic patients with clinical efficacy and safety of using.
与其他药物相比，格列美脲、格列吡嗪、格列本脲和瑞格列奈更容易导致低血糖。
Glimepiride, glipizide, glyburide and repaglinide lead to too-low blood sugar more often than other drugs do.
结论筛选的处方合理，制备工艺简单可行，制备的瑞格列奈片符合制剂质量要求。
Conclusion the reasonable formulation was obtained and preparation was simple, and the prepared tablets met the requirements.
目的：观察瑞格列奈、阿卡波糖联合治疗老年性2型糖尿病患者的临床疗效及安全性。
Objective: To observe the clinical efficacy and safety of combined treatment of repaglinide and acarbose in aged patients with diabetes type 2.
本发明涉及一种制备瑞格列奈中间体式(I)的方法，瑞格列奈为治疗糖尿病的药物。
The invention relates to a method for preparing a repaglinide intermediate in a formula (I), and repaglinide is a medicament for treating diabetes.
目的：观察瑞格列奈、阿卡波糖联合治疗老年性2型糖尿病患者的临床疗效及安全性。
Objective: To investigate the causes and clinical features of hypoglycemia in elderly patients with type 2 diabetes.
目的：观察瑞格列奈、阿卡波糖联合治疗老年性2型糖尿病患者的临床疗效及安全性。
Objective: To investigate the causes and clinical features of hypoglycemia in elderly patients with type 2 diabetes.
应用推荐